Electromed Inc. (ELMD) is approaching its fiscal first-quarter earnings release with a backdrop of steady operational performance and recent capital allocation decisions. The company, known for its SmartVest airway clearance systems, continues to expand its footprint in pulmonary care through a portfolio of devices designed for chronic respiratory and neuromuscular conditions.
Pulmonary Therapy Portfolio
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com